HOV

Hovnanian is a classic leveraged homebuilder caught in the down-leg of the rate cycle. Revenue was essentially flat in FY2025 at $2.98B (-0.9%), but net income collapsed 73.6% to $63.9M and diluted EPS fell 76.6% to $7.43, compressing net margin to just 2.1% from roughly 8% a year earlier. The MD&A explains the mechanism plainly: affordability 'remains challenging,' net contracts fell versus FY2024, and the company is buying its volume with 'aggressive' pricing, incentives, concessions and mortgage-rate buydowns funded through K. Hovnanian Mortgage. Those buydowns and QMI-home discounts are exactly what turns flat revenue into a two-thirds earnings decline — margin, not sales, is where the pain lands.

The offsetting case is valuation and balance-sheet timing. At $134.29 the stock trades around 0.3x sales and roughly 1x the $831M of stockholders' equity (~$129 book value per share), and its 18.1 P/E sits on trough EPS — against FY2024's ~$242M net income the market cap of $866M is barely 3.6x. Operating cash flow snapped back to $188M, and the debt stack is well-termed: the $925M of fixed-rate notes all mature 'thereafter' (post-2030) with no near-term wall, and the $125M secured credit facility was undrawn. That gives management room to keep buying inventory and repurchasing stock ($30.2M in FY2025).